Asian Thalassemia Conclave 2026

The Asian Thalassemia Conclave 2026, themed “Mission Thalassemia-Free India – 2035”, is a landmark international conference dedicated to uniting global leaders, clinicians, researchers, policymakers, and patient advocates in the fight against thalassemia and related hemoglobinopathies. This platform will highlight cutting-edge advances in treatment and curative options, explore innovative public health policies, and strengthen prevention strategies to reduce the burden of the disease. By bringing together expertise from both pediatric and adult hematology, the conclave aims to accelerate collaborative efforts that will pave the way for a thalassemia-free India by 2035.

OBJECTIVE

• To unite global experts, clinicians, researchers, policymakers, and patient advocates on a common platform
• Pioneering advances in thalassemia treatment, including supportive care and curative options
• To discuss and develop effective public health policies for large-scale prevention and control
• To strengthen antenatal and carrier screening initiatives to reduce the incidence of new cases
• To encourage collaboration between pediatric and adult hematology specialists for comprehensive care
• To promote research, innovation, and global best practices in the management of hemoglobinopathies
• To build momentum toward the national goal of a Thalassemia-Free India by 2035.

HIGHLIGHTS OF THE CONCLAVE

• Pioneering Scientific Sessions on transfusion strategies, gene therapy, BMT, and emerging therapies
• Panel Discussions on prevention, advocacy, and policy frameworks
• International Faculty from leading centers across Asia and Europe
• Cultural Evening & Gala Dinner
• Oral Presentations & NGO Participation